Knöbber D, Sack H, Stützer H, Rose K G
Universitäts-HNO-Klinik Homburg/Saar.
Strahlenther Onkol. 1987 Nov;163(11):706-13.
In collaboration with the Radiotherapeutic Hospital, 87 patients with squamous cell carcinomas of the oral cavity and the oropharynx were treated by combined pre-irradiation and surgical intervention at the University ORL Hospital of Cologne. The study was supposed to improve the five-year survival of patients suffering from advanced carcinomas of the head and neck area. The male and female patient's ratio was 4.5 to 1. Half of the patients had squamous cell carcinomas of the oropharynx, 21 patients had tumors of the floor of the mouth, and another 21 had tumors of the anterior two thirds of the tongue. The tumor and lymph node status was classified according to the UICC regulations (1979). In the pre-irradiation, 40 to 50 Gy were applied to the primary tumor and the regional lymph nodes. Surgery was executed generally four weeks after pre-irradiation. The tumor remission following to pre-irradiation was very good. 27% of the patients showed little or moderate post-operative disturbances in wound healing. An osteoradionecrosis was found in 4.6%. Almost 25% of the patients developed local recurrences. The cumulated five-year survival of all patients is 32%. In dependence on TNM stages, the three-year survival rates are as follows: stage I and II 80%, stage III 44%, and stage IV 40%.
在与放射治疗医院的合作中,科隆大学耳鼻喉医院对87例口腔和口咽鳞状细胞癌患者进行了放疗前和手术联合干预治疗。该研究旨在提高头颈部晚期癌症患者的五年生存率。男女患者比例为4.5比1。一半的患者患有口咽鳞状细胞癌,21例患者患有口底肿瘤,另外21例患者患有舌前三分之二的肿瘤。肿瘤和淋巴结状态根据国际抗癌联盟(UICC)1979年的规定进行分类。在放疗前,对原发肿瘤和区域淋巴结给予40至50 Gy的照射剂量。手术一般在放疗前四周进行。放疗后的肿瘤缓解情况非常好。27%的患者术后伤口愈合出现轻微或中度干扰。发现有4.6%的患者发生放射性骨坏死。近25%的患者出现局部复发。所有患者的累积五年生存率为32%。根据TNM分期,三年生存率如下:I期和II期为80%,III期为44%,IV期为40%。